What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication

Abstract

BackgroundCapturing service users’ perspectives can highlight additional and different concerns to those of clinicians, but there are no up to date, self-report psychometrically sound measures of side effects of antipsychotic medications.AimTo develop a psychometrically sound measure to identify antipsychotic side effects important to service users, the Maudsley Side Effects (MSE) measure.MethodAn initial item bank was subjected to a Delphi exercise (n = 9) with psychiatrists and pharmacists, followed by service user focus groups and expert panels (n = 15) to determine item relevance and language. Feasibility and comprehensive psychometric properties were established in two samples (N43 and N50). We investigated whether we could predict the three most important side effects for individuals from their frequency, severity and life impact.ResultsMSE is a 53-item measure with good reliability and validity. Poorer mental and physical health, but not psychotic symptoms, was related to side-effect burden. Seventy-nine percent of items were chosen as one of the three most important effects. Severity, impact and distress only predicted ‘putting on weight’ which was more distressing, more severe and had more life impact in those for whom it was most important.ConclusionsMSE is a self-report questionnaire that identifies reliably the side-effect burden as experienced by patients. Identifying key side effects important to patients can act as a starting point for joint decision making on the type and the dose of medication.

Antipsychotic treatment – a systematic literature review and meta-analysis of qualitative studies

“…Robust predictors for the early identification of these patients are still lacking, which may result in excessive use of antipsychotic medicine (Harrow, Jobe, Faull, & Yang, 2017;Moilanen et al, 2013;Murray et al, 2016;Wunderink, Nieboer, Wiersma, Sytema, & Nienhuis, 2013). Second, severe side effects, particularly associated with long-term use, include grey matter volume decrease and lateral ventricular volume increase (Fusar-Poli et al, 2013;Moncrieff & Leo, 2010), diabetes (Rajkumar et al, 2017), metabolic syndrome (Vancampfort et al, 2015), and reduced subjective quality of life and functioning (Wunderink et al, 2013;Wykes et al, 2017). Third, shared decision-making has become a stated priority in medical treatment in an attempt to reduce the use of compulsory treatment and increase subjective empowerment and adherence to treatments that are actively chosen (Leng, Clark, Brian, & Partridge, 2017).…”

The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample

“…Antipsychotic medication is the principal form of treatment for people with schizophrenia and long-term psychotic conditions. Despite their effectiveness in reducing acute symptoms and risk of relapse (Leucht et al, 2008, Leucht et al, 2012, antipsychotics produce an array of adverse effects and may contribute to reduced subjective life quality and functioning (Bebbington et al, 2009, Hofer et al, 2004, Wunderink et al, 2013, Wykes et al, 2017.…”

Is “early intervention” in bipolar disorder what it claims to be?

“…Prescribing pharmaceuticals to younger populations without first having robust empirical support for their efficacy is particularly concerning as these medications are associated with adverse side effects such as marked weight gain and consequent diabetes, extrapyramidal side effects and heightened risk of polycystic ovarian syndrome . The potential for certain antidepressants (e.g.…”